Adam Sandman, Founder and CEO of Inflectra discusses:

• Where GenAI can bring the most value in the software development lifecycle
• How productivity will improve in the software development space as a result of GenAI
• How GenAI is reshaping Inflectra's strategies and solutions
• The challenges in integrating GenAI into software testing and lifecycle management

To learn more, visit www.inflectra.com

Brian Cappellani, Chief Technology Officer, Communications and Media at Hansen Technologies discusses:

• The impact of GenAI on CSP networks
• The challenges of achieving industry-wide alignment on GenAI usage
• The importance of network telemetry and GenAI in network management, and how they optimize commerciality
• Applying intent and modelling to the commercial aspects of a CSP business, beyond network management
• The feasibility of modelling intent while modelling services

To learn more, visit www.hansencx.com

ETH Zürich's Noé Brasier, in collaboration with other researchers, has recently published an article in the scientific journal Nature on the development of wearable sensors that are capable of analyzing bodily fluids like sweat, saliva, blood and tear fluid as non-invasively as possible, potentially revolutionizing healthcare diagnostics. In this interview, Noé discusses:

• The key benefits of wearable sensors and how they will transform healthcare monitoring
• The role of high-speed connectivity in ensuring the real-time functionality of wearable sensors
• Data security and patient privacy concerns when transmitting sensitive health information via IoT devices
• The implications of wearable body-fluid sensors for remote areas or underserved populations with limited access to traditional healthcare facilities
• The predicted timeline for the widespread adoption of wearable sensors in clinical and consumer applications

To learn more, visit ethz.ch